4//SEC Filing
DOYLE THOMAS JAMES 4
Accession 0001193125-25-283562
CIK 0001422143other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:00 PM ET
Size
7.4 KB
Accession
0001193125-25-283562
Insider Transaction Report
Form 4
DOYLE THOMAS JAMES
SVP, Finance & Accounting
Transactions
- Award
Common Stock
2025-11-13+24,967→ 134,796 total - Sale
Common Stock
2025-11-14$11.18/sh−4,539$50,732→ 130,257 total
Holdings
- 500(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001910331
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:00 PM ET
- Size
- 7.4 KB